June 10th 2025
Multiple studies highlight fidaxomicin’s effectiveness across high-risk populations despite cost and access challenges, underscoring the need for education and stewardship to improve guideline adherence.
April 4th 2025
Environmental contamination plays a larger role than previously recognized, prompting calls for updated infection control strategies
April 3rd 2025
Lumen Bioscience’s, LMN-201, was considered safe and well-tolerated and there were no severe dose-related or serious adverse events reported.
February 6th 2025
Fecal microbiota transplantation emerges as the top treatment, while probiotics show limited effectiveness in preventing CDI recurrence.
January 24th 2025
Nature Medicine published additional data on Vedanta Biosciences’ Clostridioides difficile investigational therapy, VE303, from its phase 2 trial.
What Is the Vaccine Development Process?
Richard Haupt, MD, MPH, discusses the process for developing a vaccine.
Watch
Are Regulatory Agencies Dropping the Ball When It Comes to Hospital Mattress Disinfection?
Edmond Hooker, MD, DrPH, explains how regulatory agencies are “turning a blind eye” to an important issue experienced in hospitals everywhere.
Recurrent Infection: An Unmet Medical Need in the Realm of C. difficile
Dr. Richard Vickers explains how recurrent infection is an unmet medical need when it comes to C. difficile.
The Race to Develop a Safe & Effective C. difficile Vaccine
Richard Haupt, MD, MPH, discusses the different pharmaceutical companies’ efforts to develop a C. difficile vaccine.
Contemplating Regulatory Frameworks for FMT
Authors of a new Policy Forum suggest an alternative approach to regulating fecal microbiota transplantation.
Read More
Addressing the Need for a C. difficile Vaccine
Richard Haupt, MD, MPH, explains how Pfizer is addressing the need for a C. difficile vaccine.
Top 5 Contagion® News Articles for the Week of December 3rd
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Contaminated Hospital Mattresses: An Underreported Killer
Edmond Hooker, MD, DrPH, discusses how many people have fallen ill or even died due to contaminated hospital mattresses.
CDI Antibiotics Cause Collateral Damage to the Gut Microbiome
Dr. Richard Vickers explains how antibiotics to treat Clostridium difficile infection cause collateral damage to the gut microbiome.
Are FMT Capsules the Next Big Thing for Recurrent C. difficile Treatment?
A team of investigators explores if fecal microbiota transplant (FMT) capsules are just as effective as treatment via colonoscopy.
Top 5 Contagion® News Articles for the Week of November 26, 2017
Hospital Rooms Not Being Disinfected Properly: Here's Why
Edmond Hooker, MD, DrPH, discusses the reasons behind why hospital rooms are not being disinfected properly.
C. difficile Vaccine: A Primary Prevention Modality for At-Risk Individuals
Richard Haupt, MD, MPH, explains how a vaccine can serve as a primary prevention modality against C. difficile.
GenePOC C. Diff Test Approved by FDA
The FDA has cleared the molecular test which is able to detect presence of the toxin within 70 minutes.
U.S. Governors Are Applauded for Proclaiming November Clostridium difficile (C.difficile, C.diff.) Infection Awareness Month
Many US Governors have signed a state proclamation proclaiming November 2017 as Clostridium difficile Infection Awareness Month,
Why the World Needs a C. difficile Vaccine
Richard Haupt, MD, MPH, explains why a vaccine to help prevent C. difficile is so needed.
The Key to Preventing C. difficile? Reducing Antibiotics—Part 3
Check out the third portion of our exclusive interview with Maureen Spencer, Accelerate Diagnostics, as we discuss how reducing antibiotics could be key to preventing C. difficile infections.
Challenges to Disinfecting Hospital Rooms to Prevent C. difficile—Part 2
Maureen Spencer, Accelerate Diagnostics, sat down with Contagion® to discuss the challenges of disinfecting hospital rooms to prevent C. difficile.
Why Are Hospital Mattresses Harder to Disinfect Than Other Surfaces?
Edmond Hooker, MD, DrPH, explains why hospital mattresses are harder to disinfect than other harder surfaces.
Reducing <i>Clostridium Difficile</i> Infection Rates
<i>Clostridium Difficile</i>: Avoiding High-Risk Antibiotics
Fecal Transplantation in <i>Clostridium difficile</i>
<i>Clostridium difficile</i>: The Role of Bezlotoxumab
Costs of Care Considerations in <i>Clostridium difficile</i>
Fidaxomicin in the Treatment of <i>Clostridium difficile</i> Infections
Factors That Impact <i>C difficile</i> Infection Recurrence
Monitoring for Treatment Response in <i>C difficile</i>
Metronidazole vs Vancomycin in Mild <i>Clostridium difficile</i> Infections
When to Suspect Diarrhea is Symptom of a <i>Clostridium difficile</i> Infection
Community Sources of <i>Clostridium difficile</i>